Kedalion Therapeutics competitorsClear all

Kedalion Therapeutics's top competitors include Eyevance Pharmaceuticals, OrthogenRx, Enesi Pharma and Elysia.
Kedalion Therapeutics
Kedalion Therapeutics
Kedalion Therapeutics is an ophthalmic drug company focused on the delivery of ocular medicines.
Eyevance Pharmaceuticals
Eyevance Pharmaceuticals
Eyevance Pharmaceuticals is a company that develops ophthalmic therapies for the ocular surface and anterior segment.
OrthogenRx
OrthogenRx
OrthogenRx is a medical device company focused on the development and commercialization of treatments for knee pain caused by osteoarthritis (OA).
Enesi Pharma
Enesi Pharma
Enesi Pharma is a pharmaceutical company developing injectable solid dose drug-device vaccine products.
Elysia
Elysia
Elysia (Elysia-raytest) is a company that develops and manufactures instruments and solutions for the life sciences market.
Founding Date
Founding Date
2015
Founding Date
2017
Founding Date
2012
Founding Date
2017
Founding Date
2014
Type
Type
Private
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Menlo Park, US HQ
Locations
Fort Worth, US HQ
Fort Worth, US
Locations
Doylestown, US HQ
Locations
Milton, GB HQ
Locations
Liège, BE HQ
Liège, BE
Straubenhardt, DE
Employees
Employees
7
Employees
704% increase
Employees
3310% increase
Employees
29
Employees
343% decrease
Twitter followers
Twitter followers
N/A
Twitter followers
168
Twitter followers
29
Twitter followers
138
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
7
Number of tweets (last 30 days)
9
Number of tweets (last 30 days)
10
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1
Average likes per tweet (last 30 days)
1.1
Average likes per tweet (last 30 days)
0.8
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
85.71%
Percentage of tweets with engagement (last 30 days)
88.89%
Percentage of tweets with engagement (last 30 days)
60%
Percentage of tweets with engagement (last 30 days)
N/A

Funding

Latest funding round
Latest funding round
$ 5m (almost 3 years ago)
Latest funding round
$ 30k (over 1 year ago)
Latest funding round
$ 50k (over 4 years ago)
Latest funding round
N/A
Latest funding round
N/A
Total funding raised
Total funding raised
$ 5m
Total funding raised
$ 30k
Total funding raised
$ 2.7m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Eyevance Pharmaceuticals
HQ
Fort Worth, US
Employees
70↑ 4% increase

Eyevance Pharmaceuticals is a company that develops ophthalmic therapies for the ocular surface and anterior segment.

View company
OrthogenRx
HQ
Doylestown, US
Employees
33↑ 10% increase

OrthogenRx is a medical device company focused on the development and commercialization of treatments for knee pain caused by osteoarthritis (OA).

View company
Enesi Pharma
HQ
Milton, GB
Employees
29

Enesi Pharma is a pharmaceutical company developing injectable solid dose drug-device vaccine products.

View company
Elysia
HQ
Liège, BE
Employees
34↓ 3% decrease

Elysia (Elysia-raytest) is a company that develops and manufactures instruments and solutions for the life sciences market.

View company